(Q84525251)
Statements
Antiangiogenic agents for the treatment of nonsmall cell lung cancer: characterizing the molecular basis for serious adverse events (English)
Shenhong Wu
Roger S. Keresztes
1 August 2011
scientific article published on 01 August 2011
No description defined